Serge Belanger
Stock Analyst at Needham
(3.79)
# 787
Out of 4,479 analysts
229
Total ratings
46.54%
Success rate
8.58%
Average return
Main Sectors:
Top Industries:
21 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Reiterates: Buy | $10 | $4.15 | +140.96% | 12 | Jun 19, 2024 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $35 | $11.67 | +199.91% | 12 | Jun 18, 2024 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $30 | $12.25 | +144.90% | 9 | Jun 11, 2024 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $66 | $41.49 | +59.09% | 8 | Jun 10, 2024 | |
| OMER Omeros | Reiterates: Hold | n/a | $3.87 | - | 2 | Jun 4, 2024 | |
| LQDA Liquidia | Reiterates: Buy | $28 | $11.88 | +135.79% | 19 | Jun 3, 2024 | |
| CYTK Cytokinetics | Maintains: Buy | $108 → $72 | $54.41 | +32.33% | 14 | May 23, 2024 | |
| AMPH Amphastar Pharmaceuticals | Reiterates: Hold | n/a | $37.62 | - | 3 | May 22, 2024 | |
| VRCA Verrica Pharmaceuticals | Reiterates: Buy | $16 | $7.85 | +103.82% | 12 | May 16, 2024 | |
| HRTX Heron Therapeutics | Reiterates: Buy | $5 | $2.85 | +75.75% | 14 | May 16, 2024 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $18 | $9.02 | +99.67% | 12 | May 15, 2024 | |
| CLSD Clearside Biomedical | Reiterates: Buy | $4 | $1.25 | +220.00% | 7 | May 13, 2024 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $62 | $36.95 | +67.79% | 9 | May 10, 2024 | |
| COLL Collegium Pharmaceutical | Downgrades: Hold | n/a | $32.57 | - | 20 | May 10, 2024 | |
| RVNC Revance Therapeutics | Maintains: Buy | $18 → $12 | $2.44 | +391.80% | 15 | May 10, 2024 | |
| TRVI Trevi Therapeutics | Reiterates: Buy | $8 | $2.80 | +185.71% | 11 | May 8, 2024 | |
| EOLS Evolus | Reiterates: Buy | $22 | $10.74 | +104.84% | 9 | May 8, 2024 | |
| PCRX Pacira BioSciences | Maintains: Buy | $45 → $43 | $22.47 | +91.41% | 18 | May 8, 2024 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $8 | $2.41 | +231.95% | 14 | May 7, 2024 | |
| BCRX BioCryst Pharmaceuticals | Reiterates: Buy | $12 | $6.62 | +81.41% | 8 | May 7, 2024 | |
| AKBA Akebia Therapeutics | Downgrades: Hold | n/a | $0.97 | - | 1 | Mar 31, 2022 |
CorMedix
Jun 19, 2024
Reiterates: Buy
Price Target: $10
Current: $4.15
Upside: +140.96%
KalVista Pharmaceuticals
Jun 18, 2024
Reiterates: Buy
Price Target: $35
Current: $11.67
Upside: +199.91%
Viridian Therapeutics
Jun 11, 2024
Reiterates: Buy
Price Target: $30
Current: $12.25
Upside: +144.90%
MoonLake Immunotherapeutics
Jun 10, 2024
Reiterates: Buy
Price Target: $66
Current: $41.49
Upside: +59.09%
Omeros
Jun 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $3.87
Upside: -
Liquidia
Jun 3, 2024
Reiterates: Buy
Price Target: $28
Current: $11.88
Upside: +135.79%
Cytokinetics
May 23, 2024
Maintains: Buy
Price Target: $108 → $72
Current: $54.41
Upside: +32.33%
Amphastar Pharmaceuticals
May 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $37.62
Upside: -
Verrica Pharmaceuticals
May 16, 2024
Reiterates: Buy
Price Target: $16
Current: $7.85
Upside: +103.82%
Heron Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $5
Current: $2.85
Upside: +75.75%
Arcutis Biotherapeutics
May 15, 2024
Maintains: Buy
Price Target: $16 → $18
Current: $9.02
Upside: +99.67%
Clearside Biomedical
May 13, 2024
Reiterates: Buy
Price Target: $4
Current: $1.25
Upside: +220.00%
Xenon Pharmaceuticals
May 10, 2024
Maintains: Buy
Price Target: $62
Current: $36.95
Upside: +67.79%
Collegium Pharmaceutical
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $32.57
Upside: -
Revance Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $18 → $12
Current: $2.44
Upside: +391.80%
Trevi Therapeutics
May 8, 2024
Reiterates: Buy
Price Target: $8
Current: $2.80
Upside: +185.71%
Evolus
May 8, 2024
Reiterates: Buy
Price Target: $22
Current: $10.74
Upside: +104.84%
Pacira BioSciences
May 8, 2024
Maintains: Buy
Price Target: $45 → $43
Current: $22.47
Upside: +91.41%
Esperion Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $8
Current: $2.41
Upside: +231.95%
BioCryst Pharmaceuticals
May 7, 2024
Reiterates: Buy
Price Target: $12
Current: $6.62
Upside: +81.41%
Akebia Therapeutics
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.97
Upside: -